ClinicalTrials.gg
Not yet recruitingNCT07435220Updated Oct 30, 2026

Robot-Assisted Meditation for Older Adults With Cognitive Concerns

An interventional study of Robot-Guided Meditation and Audio-Only Robot in Cognitive Impairment and Perceived Stress, sponsored by Johns Hopkins University. Not yet recruiting. Open to participants aged 65 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by Johns Hopkins University · Not applicable, Interventional, and Treatment

How we know

Updated Oct 30, 2026Start date movedPrimary completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
65 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 34 studies in Cognitive Dysfunction by Johns Hopkins University — 13 open to participants now, 15 under way, 1 of them phase 3. Cognitive Dysfunction · Johns Hopkins University.

Planned enrollment
7th of 33
100 · median 52
Started
2027
with 1 other
No phase
22 of 34
8 open now
Primary completion
2027-12
later than 8 of 14 live
Registered
31st of 34
by date

Among the 34 studies in Cognitive Dysfunction by Johns Hopkins University, this one is the 7th largest by planned enrollment of the 33 interventional ones that give a count, is one of 2 that started in 2027, is one of 22 with no phase, reaches primary completion later than 8 of the 14 other live ones, and was the 31st registered.

Cognitive Dysfunction

3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.

Browse Cognitive Dysfunction studies →

Open to participants now

13 of the 34 studies in Cognitive Dysfunction by Johns Hopkins University are open now, in 1 country. Recruiting first, the newest first:

7 more — sign in →

By country, each count listing its studies:

All 13 open studies →

Where they have run

Who these studies take

Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.

This study: 65 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Cognitive Dysfunction by Johns Hopkins University, or all of them as a file.
02

Study summary

While traditional app-based mindfulness meditation programs relying solely on audio guidance have shown potential benefits for older adults, the programs often face challenges such as low engagement. Participants frequently report difficulties in maintaining focus during meditation sessions, which can limit its effectiveness in improving outcomes such as stress reduction and sleep quality. To address these limitations, this study examines whether a haptic robot that provides both tactile and audio guidance can enhance meditation. The robot's expansion and contraction movements help users pace and sustain rhythmic breathing, while gentle vibrations signal phase transitions without disrupting concentration. These haptic features are intended to anchor attention and support a more embodied practice.

The study primarily seeks to answer the following questions: Does a haptic enabled meditation intervention reduce perceived stress in older adults living alone with subjective cognitive decline more effectively than an audio only mindfulness meditation guidance provided by a non-moving robot? To what extent does enhanced attentional anchoring mediate the intervention's effect on perceived stress in this population? By addressing these questions, the research aims to determine whether haptic enabled meditation technology can overcome common barriers to mindfulness practice among older adults and serve as an innovative tool to reduce perceived stress, and ultimately improve their sleep quality and physical, emotional, and cognitive well being.

Read the detailed description

While traditional app-based mindfulness meditation programs relying solely on audio guidance have shown potential benefits for older adults, the apps often face challenges such as low compliance. Participants frequently report difficulties in maintaining focus during meditation sessions, which can limit its effectiveness in improving outcomes such as stress reduction and sleep quality. Recognizing these limitations, this study explores whether a haptic-enabled handheld robot can enhance meditation practices by providing both haptic and audio guidance. The robot, designed to foster sustained attention and encourage rhythmic breathing, may offer a novel, multidimensional approach that addresses compliance issues and supports deeper engagement in mindfulness meditation.

The study primarily seeks to answer the question: Does robot-guided meditation, combining both haptic and audio guidance, improve the sleep quality of older adults living alone with subjective cognitive decline more effectively than traditional audio-based mindfulness meditation guidance? Furthermore, the study examines a secondary question: Is the effect of robot-guided meditation on sleep quality mediated by reductions in stress? By investigating these questions, the research aims to offer insights into whether haptic-enabled meditation technology can overcome common barriers to mindfulness practices among older adults and serve as an innovative tool to improve physical, emotional, and cognitive well-being.

Aim 1: This aim will evaluate the effectiveness of robot-guided meditation, a novel approach that combines haptic feedback and audio guidance, in reducing stress levels among older adults living alone with subjective cognitive decline. Stress levels will be measured using the Perceived Stress Scale (PSS). The haptic-enabled intervention aims to enhance focus, engagement, and stress reduction more effectively than audio-only methods, addressing challenges like low adherence and distraction in mindfulness practices.

Aim 2: This aim explores the role of stress reduction as a mediator between robot-guided meditation and improved sleep quality. Sleep will be assessed through the Pittsburgh Sleep Quality Index (PSQI) and Fitbit data, measuring self-reported and objective sleep outcomes like restlessness and time awake. The study will clarify whether reduced stress drives better sleep outcomes.

Aim 3: This aim will examine adherence to and usability of the robot-guided meditation intervention. Adherence will be tracked through self-reported practice logs and usage data. By evaluating how older adults interact with and engage with this technology, the study will provide insights into the practicality of implementing this approach for individuals experiencing subjective cognitive decline.

03

Conditions studied

  • Cognitive Impairment
  • Perceived Stress

Keywords

  • Meditation
  • Robot
  • Older adults
  • Cognitive concerns
  • Robot-Guided Intervention
  • Audio-Guided Control
04

Who can participate

Ages eligible
65 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants have subjective cognitive decline, assessed using the Subjective Cognitive Decline Questionnaire (SCD-Q)

Exclusion criteria

Exclusion Criteria:

  • Participants do not have dementia or mild cognitive impairment.
  • To exclude significant cognitive impairment, investigators will utilize the (MMSE) and Montreal Cognitive Assessment (MoCA).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Robot-Guided

    A handheld robot provides daily mindfulness meditation sessions that include both haptic and audio guidance.

    Behavioral: Robot-Guided Meditation

  • Active comparator
    Non-Moving Robot

    Participants use the same robot, which remains stationary (no haptic movement) and provides audio-only daily meditation sessions.

    Behavioral: Audio-Only Robot

Interventions

  • BehavioralRobot-Guided Meditation

    A handheld robot provides daily mindfulness meditation sessions that include both haptic and audio guidance.

  • BehavioralAudio-Only Robot

    Participants use the same robot, which remains stationary (no haptic movement) and provides audio-only daily meditation sessions.

06

What researchers measure

Primary outcomes

  1. Stress level as assessed by the Perceived Stress Scale (PSS)

    Perceived Stress Scale (PSS). The total score ranges 0 to 40. Low Stress: 0-13; Moderate Stress: 14-26; High Stress: 27-40. A higher score indicates a higher level of perceived stress.

    Time frame: Baseline, 4 weeks, 8 weeks

Secondary outcomes

  1. Sleep quality as assessed by the Pittsburgh Sleep Quality Index (PSQI)

    Pittsburgh Sleep Quality Index (PSQI). The total score range 0 to 21, where a score greater than 5 indicates poor sleep quality. A higher score indicates worse sleep quality.

    Time frame: Baseline, 4 weeks, 8 weeks

  2. Anxiety as assessed by the Generalized Anxiety Disorder scale (GAD-7)

    Generalized Anxiety Disorder scale (GAD-7). The total score ranges from 0 to 21. A score of 10 or higher is often used as a cutoff suggesting clinically significant anxiety. A higher score indicates worse anxiety.

    Time frame: Baseline, week 4, week 8

Other outcomes

  1. Adherence

    Adherence is defined as the number of days a participant completes the required meditation sessions. Adherence will be tracked through self-reported practice logs and usage data.

    Time frame: From enrollment up to end of treatment at 8 weeks

07

Study locations

No study locations are listed for this record.

08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2027; primary completion for Dec 2027, 10 months later.

Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's planned 10 months is below that.

Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 30, 2026: start Nov 2026 → Feb 2027 and primary completion Oct 2027 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 20, 2026
First posted
Feb 27, 2026
StartEst.
Feb 1, 2027was Nov 2026
Primary completionEst.
Dec 31, 2027was Oct 2027
CompletionEst.
Dec 31, 2027
Last update
Oct 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Nov 1, 2026→Feb 1, 2027
Oct 30, 2026
Primary completion
Oct 31, 2027→Dec 31, 2027
Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    Start date Nov 1, 2026→Feb 1, 2027
    Primary completion Oct 31, 2027→Dec 31, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07435220
Responsible party
Sponsor
First posted
Feb 27, 2026
Start date
Feb 1, 2027 (estimated)
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Oct 30, 2026

Study contacts

Chien-Ming Huang, PhD
Contact
chienming.huang@jhu.edu
404-932-6567
Chien-Ming Huang, PhD
principal investigator · Johns Hopkins University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion